Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 728,689
  • Shares Outstanding, K 37,216
  • Annual Sales, $ 344,290 K
  • Annual Income, $ 16,340 K
  • 60-Month Beta 0.71
  • Price/Sales 2.12
  • Price/Cash Flow 14.20
  • Price/Book 1.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/19
See More
  • Average Estimate 0.25
  • Number of Estimates 2
  • High Estimate 0.26
  • Low Estimate 0.25
  • Prior Year 0.20
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.46 +5.63%
on 06/03/19
20.03 -2.65%
on 05/17/19
-0.02 (-0.10%)
since 05/14/19
3-Month
18.46 +5.63%
on 06/03/19
25.48 -23.47%
on 04/01/19
-2.19 (-10.10%)
since 03/14/19
52-Week
18.11 +7.68%
on 12/21/18
25.48 -23.47%
on 04/01/19
-2.27 (-10.43%)
since 06/14/18

Most Recent Stories

More News
AngioDynamics Divests NAMIC Portfolio to Medline Industries

The NAMIC fluid management portfolio sale clears all of AngioDynamics' (ANGO) outstanding debt.

VAR : 130.88 (-0.91%)
ARAY : 3.71 (-0.27%)
MYGN : 24.01 (-7.62%)
ANGO : 19.50 (-0.41%)
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that...

NDAQ : 95.71 (+0.28%)
ANGO : 19.50 (-0.41%)
AngioDynamics IDE Application for NanoKnife Gets FDA Nod

AngioDynamics' (ANGO) pilot study is intended to support the approval of a future PMA in the United States.

PEN : 166.83 (+1.96%)
ANGO : 19.50 (-0.41%)
XRAY : 56.77 (-0.35%)
CNMD : 82.42 (-1.94%)
AngioDynamics Announces First Patient Enrolled in NanoKnife(R) DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced enrollment...

ANGO : 19.50 (-0.41%)
Why Is AngioDynamics (ANGO) Down 12.1% Since Last Earnings Report?

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ANGO : 19.50 (-0.41%)
AngioDynamics Announces Agreement to Sell NAMIC(R) Fluid Management Business to Medline Industries, Inc. for $167.5 Million

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, today announced that...

ANGO : 19.50 (-0.41%)
Report: Developing Opportunities within 22nd Century Group, Darling Ingredients, Silvercorp Metals, Trevena, Star Bulk Carriers, and AngioDynamics -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of 22nd Century Group, Inc (NYSE:XXII),...

TRVN : 1.06 (-1.85%)
DAR : 19.49 (-1.27%)
SBLK : 7.81 (-2.86%)
XXII : 1.96 (-2.97%)
SVM : 2.16 (-2.70%)
ANGO : 19.50 (-0.41%)
AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates

Despite strength in the VIT business, AngioDynamics (ANGO) exited third-quarter fiscal 2019 on a tepid note, with both earnings and revenues missing estimates.

TCMD : 53.27 (-1.77%)
PEN : 166.83 (+1.96%)
ANGO : 19.50 (-0.41%)
FLDM : 12.25 (+0.25%)
AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study

AngioDynamics' (ANGO) launches AngioDIRECT.com for enrolling participants as part of the DIRECT clinical study.

TCMD : 53.27 (-1.77%)
PEN : 166.83 (+1.96%)
ANGO : 19.50 (-0.41%)
FLDM : 12.25 (+0.25%)
AngioDynamics (ANGO) Lags Q3 Earnings and Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of -13.64% and -2.44%, respectively, for the quarter ended February 2019. Do the numbers hold clues to what lies ahead for the stock?

ANGO : 19.50 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ANGO with:

Business Summary

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad...

See More

Key Turning Points

2nd Resistance Point 19.76
1st Resistance Point 19.63
Last Price 19.50
1st Support Level 19.39
2nd Support Level 19.28

See More

52-Week High 25.48
Fibonacci 61.8% 22.66
Fibonacci 50% 21.80
Fibonacci 38.2% 20.93
Last Price 19.50
52-Week Low 18.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar